Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Harvard Business School
AstraZeneca
Express Scripts
McKinsey

Last Updated: January 26, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR EPINEPHRINE

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

All Clinical Trials for Epinephrine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000290 Stress Hormones and Human Cocaine Use - 7 Completed University of Minnesota - Clinical and Translational Science Institute Phase 1 1997-05-01 The purpose of this study is to determine the HPA axis and adrenergic system activation in response to cocaine administration.
NCT00000290 Stress Hormones and Human Cocaine Use - 7 Completed National Institute on Drug Abuse (NIDA) Phase 1 1997-05-01 The purpose of this study is to determine the HPA axis and adrenergic system activation in response to cocaine administration.
NCT00001724 Local Flurbiprofen to Treat Pain Following Wisdom Tooth Extraction Completed National Institute of Dental and Craniofacial Research (NIDCR) Phase 2 1997-11-01 This study will evaluate the effectiveness of the non-steroidal anti-inflammatory drug flurbiprofen (Ansaid® (Registered Trademark)) in relieving pain following oral surgery. Flurbiprofen is approved by the Food and Drug Administration for treatment of arthritis pain. Patients 16 years of age and older requiring third molar (wisdom tooth) extraction may be eligible for this study. Patients will undergo oral surgery to remove two lower third molar teeth. Before surgery, they will be given a local anesthetic (lidocaine with epinephrine) injected in the mouth and a sedative (Versed) infused through a catheter (thin plastic tube) placed in an arm vein. At the time of surgery, patients will also be given flurbiprofen or a placebo formulation (look-alike substance with no active ingredient) directly into the extraction site and a capsule that also may contain flurbiprofen or placebo. One in seven patients will receive only placebo. All patients will fill out pain questionnaires and stay in the clinic for up to 6 hours for observation of bleeding and medication side effects. Patients who do not have satisfactory pain relief from the test medicine after surgery may request a standard pain reliever. A small blood sample will be collected during surgery and at 15 minutes, one-half hour and 1, 2, 3, 4, 5, 6, 24 and 48 hours after surgery to measure flurbiprofen blood levels. A total of 33 ml (about 2 tablespoons) of blood will be drawn for these tests. Samples collected on the day of surgery will be drawn from the catheter used to administer the sedative; the 24- and 48-hour samples will be taken by needle from an arm or hand vein. Urine samples will also be collected between 4 and 6 hours after surgery and again at 24 and 48 hours after surgery.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Epinephrine

Condition Name

Condition Name for Epinephrine
Intervention Trials
Pain 37
Postoperative Pain 24
Pain, Postoperative 19
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Epinephrine
Intervention Trials
Pain, Postoperative 53
Bronchiolitis 22
Pulpitis 19
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Epinephrine

Trials by Country

Trials by Country for Epinephrine
Location Trials
United States 290
Canada 34
Korea, Republic of 23
Egypt 20
Brazil 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Epinephrine
Location Trials
California 35
New York 21
Maryland 20
Texas 19
Pennsylvania 19
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Epinephrine

Clinical Trial Phase

Clinical Trial Phase for Epinephrine
Clinical Trial Phase Trials
Phase 4 161
Phase 3 44
Phase 2/Phase 3 19
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Epinephrine
Clinical Trial Phase Trials
Completed 194
Recruiting 113
Not yet recruiting 88
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Epinephrine

Sponsor Name

Sponsor Name for Epinephrine
Sponsor Trials
University of Minnesota - Clinical and Translational Science Institute 9
Amphastar Pharmaceuticals, Inc. 7
University of North Carolina, Chapel Hill 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Epinephrine
Sponsor Trials
Other 599
Industry 64
NIH 19
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
McKesson
Dow
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.